1. 464OInduction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations: The LOGIK0902/OLCSG0905 intergroup phase II study. (24th November 2019) Authors: Saeki, S; Hotta, K; Yamaguchi, M; Harada, D; Bessho, A; Tanaka, K; Inoue, K; Gemba, K; Inoue, K; Ichihara, E; Kishimoto, J; Sasaki, T; Shioyama, Y; Katsui, K; Sasaki, J; Kiura, K; Sugio, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 534TiPA randomized phase III study of carboplatin plus nab-paclitaxel with or without nintedanib for NSCLC with IPF (J-SONIC). (24th November 2019) Authors: Otsubo, K; Kishimoto, J; Kenmotsu, H; Minegishi, Y; Horinouchi, H; Kato, T; Ichihara, E; Shiraki, A; Atagi, S; Ando, M; Yamamoto, N; Okamoto, I Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quantitative 3D and 2D Head Ultrasound to Determine Thresholds for Intervention In Preterm Neonates with Posthemorrhagic Ventricular Dilation. (1st June 2016) Authors: Kishimoto, J; Lee, D S.C.; Salehi, F; Romano, W; Fenster, A; Ribaupierre, S de Journal: Paediatrics & Child Health Issue: Volume 21(2016)Supplement 5 Page Start: e86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗